CD

Christopher DelOrefice

ResMed Inc. | Non-Executive Director
Mr DelOrefice currently serves as executive vice president and chief financial officer (CFO) of Becton, Dickinson and Company (NYSE: BDX), including responsibility for the Information Technology and Global Services and the Strategy and Corporate Development organizations. He brings over 30 years of audit, accounting, finance, operational, and strategic expertise. Before joining BD in September 2021, Mr. DelOrefice served in many roles at Johnson & Johnson (NYSE: JNJ) including most recently as vice president of investor relations and previously as CFO of J&J's consumer and medical device business segments for North America, along with roles in finance leadership for supply chain, corporate mergers and acquisitions, consumer research and development, and business development for J&J's North America pharmaceutical business. Before J&J, Mr. DelOrefice held positions of increasing responsibility in accounting, financial reporting, global audit, and supply chain finance at AstraZeneca (LON: AZN), AET Films, and Ametek (NYSE: AME).

Company and Role

Company
Title
Tenure
Since
RMD
ResMed Inc.
  • Non-Executive Director
1yrs, 9mthAug 2024

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RMD
ResMed Inc.
N/AN/AN/AN/A